MARIA OLGA
CAAMAÑO SANTOS
Investigadora no período 1991-2021
Ikerbasque, Fundación Vasca para la Ciencia
Bilbao, EspañaPublicacións en colaboración con investigadores/as de Ikerbasque, Fundación Vasca para la Ciencia (8)
2021
-
Synthesis, Pharmacological, and Biological Evaluation of 2-Furoyl-Based MIF-1 Peptidomimetics and the Development of a General-Purpose Model for Allosteric Modulators (ALLOPTML)
ACS Chemical Neuroscience, Vol. 12, Núm. 1, pp. 203-215
2018
-
Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l -Prolyl- l -leucyl-glycinamide Peptidomimetics
ACS Chemical Neuroscience, Vol. 9, Núm. 11, pp. 2572-2587
2017
-
Multi-target mining of alzheimer disease proteome with Hansch’s QSBR-perturbation theory and experimental-theoretic study of new thiophene isosters of rasagiline
Current Drug Targets, Vol. 18, Núm. 5, pp. 511-521
2016
-
Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives
Neuropharmacology, Vol. 103, pp. 270-278
-
Experimental-theoretic approach to drug-lymphocyte interactome networks with flow cytometry and spectral moments perturbation theory
Current Pharmaceutical Design, Vol. 22, Núm. 33, pp. 5114-5119
2014
-
Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1,2-rasagiline carbamates
International Journal of Molecular Sciences, Vol. 15, Núm. 9, pp. 17035-17064
2013
-
Model for high-throughput screening of multitarget drugs in chemical neurosciences: Synthesis, assay, and theoretic study of rasagiline carbamates
ACS Chemical Neuroscience, Vol. 4, Núm. 10, pp. 1393-1403
-
TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases
Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 7, pp. 1870-1879